When does Alcon report earnings and how could that move ALC.SW stock?

Alcon reports on 24 Feb 2026. Earnings, guidance, and surgical volumes can move ALC.SW stock sharply. Expect wider intraday spreads and volatility as traders price new revenue and margin signals.

What are the main valuation metrics to watch for ALC.SW stock?

Key metrics include **PE 39.93**, **P/S 4.03**, **EV/EBITDA 21.80**, and free cash flow per share **3.22**. These show premium valuation versus some healthcare peers and set expectations for growth.

What does Meyka AI forecast for ALC.SW stock and what is the caveat?

Meyka AI's forecast model projects **CHF 61.27** for the year, an implied **-3.96%** from CHF **63.78** today. Forecasts are model-based projections and not guarantees.

What are the main risks that could hurt ALC.SW stock after earnings?

Risks include weaker surgical procedure volumes, margin compression, and slower Vision Care sales. Currency swings and reimbursement pressures could also weigh on ALC.SW stock performance.

CH Stocks

ALC.SW Alcon (SIX) 23 Feb 2026 market closed: CHF63.78 ahead of earnings

ByHuzaifa Zahoor February 23, 2026February 23, 2026

ALC.SW stock closed at CHF 63.78 on 23 Feb 2026 as markets shut ahead of Alcon’s quarterly report. The eye-care group reports results on 24 Feb 2026, and investors watch revenue, surgical procedure volumes, and margin recovery. Current metrics show EPS 1.61 and PE 39.93, with volume at 1,077,533 shares. This earnings spotlight focuses on what the numbers imply for price action on the SIX Swiss Exchange and short-term guidance for 2026.